Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Intensity Therapeutics In...

    NASDAQ: INTS · Real-Time Price · USD
    0.33
    -0.25 (-43.01%)
    At close: Jun 12, 2025, 3:59 PM

    Intensity Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 147K 179.04K n/a
    Gross Profit
    		 n/a -147K -179.04K n/a
    Operating Income
    		 -16.59M -8.32M -7.63M -8.01M
    Interest Income
    		 314K 324K 2.48K 2.61K
    Pretax Income
    		 -16.27M -10.54M -7.58M -7.9M
    Net Income
    		 -16.27M -10.54M -7.45M -7.89M
    Selling & General & Admin
    		 6.09M 3.39M 2.42M 2.16M
    Research & Development
    		 10.5M 4.79M 5.13M 5.86M
    Other Expenses
    		 n/a n/a 47.65K 115.51K
    Operating Expenses
    		 16.59M 8.17M 7.55M 8.01M
    Interest Expense
    		 n/a 305K 81.78K 16.77K
    Selling & Marketing Expenses
    		 n/a -147K n/a n/a
    Cost & Expenses
    		 n/a 8.32M 7.55M 8.01M
    Income Tax Expense
    		 n/a n/a -131.91K -2.61K
    Shares Outstanding (Basic)
    		 13.91M 8.62M 13.1M 13.1M
    Shares Outstanding (Diluted)
    		 13.91M 8.62M 13.1M 13.1M
    EPS (Basic)
    		 -1.17 -1.38 -0.57 -0.6
    EPS (Diluted)
    		 -1.17 -1.38 -0.57 -0.6
    EBITDA
    		 -16.24M -10.09M -7.4M -7.88M
    EBIT
    		 -16.27M -10.23M -7.58M -7.9M
    Depreciation & Amortization
    		 25K 147K 179.04K 236.56K

    Add to Watchlist